abs265.txt	current	strategies	aimed	to	cure	hiv	infection	are	based	on	combined	efforts	toreactivate	the	virus	from	latency	and	improve	immune	effector	cell	function	toclear	infected	cells		these	strategies	are	primarily	focused	on	cd8+	t	cells	andapproaches	are	challenging	due	to	insufficient	hiv	antigen	production	frominfected	cells	and	poor	hiv-specific	cd8+	t	cells		γδ	t	cells	represent	a	uniquesubset	of	effector	t	cells	that	can	traffic	to	tissues		and	selectively	targetcancer	or	virally	infected	cells	without	requiring	mhc	presentation		we	analyzedwhether	γδ	t	cells	represent	a	complementary/alternative	immunotherapeuticapproach	towards	hiv	cure	strategies		γδ	t	cells	from	hiv-infected	virologicallysuppressed	donors	were	expanded	with	bisphosphonate	pamidronate	(pam)	and	cellswere	used	in	autologous	cellular	systems	ex	vivo		these	cells	(a)	are	potentcytotoxic	effectors	able	to	efficiently	inhibit	hiv	replication	ex	vivo		(b)degranulate	in	the	presence	of	autologous	infected	cd4+	t	cells		and	(c)specifically	clear	latently	infected	cells	after	latency	reversal	withvorinostat		this	is	the	first	proof	of	concept	to	our	knowledge	showing	that	γδ	tcells	target	and	clear	autologous	hiv	reservoirs	upon	latency	reversal		ourresults	open	potentially	new	insights	into	the	immunotherapeutic	use	of	γδ	tcells	for	current	interventions	in	hiv	eradication	strategies	
